Abstract:Objective To observe the levels of the placenta growth factor(PLGF), the homocysteine(Hcy), the folic acid(Fa) and the Vitamin B12(Vit B12) in the maternal blood and the umbilical cord blood, and study the correlation and the mutual influence on the level of the fetal growth restriction(FGR). Methods The 44 inpatient delivery mothers and their babies were selected from Feb.to Nov.2010 in the Third Affiliated Hospital of Inner Mongolia Medical University, according to the womb age with birth weight percentile, and they were divided into 3 groups: the FGR group, appropriate for gestational age(AGA) group, large for gestational age(LGA) group.The fetal birth weight, height, head circumference, abdominal circumference, placenta weight were measured, and body mass index(BMI) was calculated, neonatal growth status was evaluated, and the delivery method and gender were recorded, and the Hcy, Fa, Vit B12 levels in the maternal blood and the umbilical cord blood were detected by enzyme-linked immunosorbent assay, respectively. Results 1.The Fa, Vit B12 levels in the maternal blood, umbilical cord blood in FGR group were obviously lower than those in the LGA group and AGA group(all P<0.05, 0.01). The Hcy levels in the maternal blood, umbilical cord blood in FGR group were obviously higher than those in the LGA group, AGA group(all P<0.05). The PLGF levels in the maternal blood, umbilical cord blood of FGR group were remarkably lower than those in the LGA group and AGA group(P<0.05, 0.01). In the maternal blood and umbilical cord blood, the Fa, Vit B12 levels, were positively correlated with PLGF(all P<0.001).2.The Hcy level in the maternal blood and umbilical cord blood, were negatively correlated with fetal birth weight, height, head circumference, abdominal circumference, placenta weight, BMI(all P<0.05). In the pregnant women blood Fa level, compared with fetal birth weight, head circumference, abdominal circumference, placenta weight, and BMI, were positively correlated(all P<0.05). In the maternal blood Vit B12 level, compared with fetal birth head circumference, abdominal circumference, and BMI, were positively correlated(all P<0.05). In the maternal blood PLGF level, compared with fetal birth weight, head circumference, abdominal circumfe-rence, BMI, was positively correlated(all P<0.05). By the stepwise multiple regression analysis, screening out the maternal blood Fa, Hcy, the umbilical cord blood Hcy influenced the fetal birth weight obviously, the most influent factor for the placenta weight was the maternal blood Hcy.3.The placenta weight in FGR group was lower than that of the LGA group and AGA group(P<0.001), and in the LGA group, AGA group, fetal birth weight, height, head circumfe-rence, abdominal circumference, BMI, compared with the placenta weight, were positively correlated(all P<0.001). Conclusions 1.Hyperhomocysteinemia may happen during pregnancy for the lack of the Fa and Vit B12, and FGR attacks may be related to the rise of Hcy level.2.In the later period of the pregnant women, the Fa, Vit B12, Hcy levels have the severe influence on the fetal physical condition.3.Placenta weight plays an important role in the fetal growth and development.4.The PLGF hyposecretion of the placenta may be the one of the key links to the pathogenesis of the FGR. Key words: Fetal growth restriction; Homocysteine; Folic acid; Vitamin B12; Placenta growth factor

Fetal growth restriction induced by maternal gal-3 deficiency is associated with altered gut-placenta axis

Galectin-1 Expression in the Serum and Placenta of Pregnant Women with Fetal Growth Restriction and Its Significance

Fetal Growth Restriction: Does an Integrated Maternal Hemodynamic-Placental Model Fit Better?

[The Involvement of Galectin-1 in Implantation and Pregnancy Maintenance at the Maternal-Fetal Interface].

Integrated Bioinformatics Analysis to Screen Hub Gene Signatures for Fetal Growth Restriction

Integrated Analysis of Key Genes and Pathways Involved in Fetal Growth Restriction and Their Associations With the Dysregulation of the Maternal Immune System

Blocking OLFM4/galectin-3 axis in placental polymorphonuclear myeloid-derived suppressor cells triggers intestinal inflammation in newborns

The placental blood perfusion and LINC00473-mediated promotion of trophoblast apoptosis in fetal growth restriction

Decreased PGF May Contribute to Trophoblast Dysfunction in Fetal Growth Restriction.

FGR-associated Placental Insufficiency and Capillary Angiogenesis Involves Disruptions in Human Placental Mirnas and Mrnas

IL-27 Deficiency Inhibits Proliferation and Invasion of Trophoblasts Via the SFRP2/Wnt/β-catenin Pathway in Fetal Growth Restriction.

Placental Galectins Are Key Players in Regulating the Maternal Adaptive Immune Response

Fetal growth restriction exhibits various mTOR signaling in different regions of mouse placentas with altered lipid metabolism

Progress in the understanding of the etiology and predictability of fetal growth restriction

Dysfunction of Tregs Contributes to FGR Pathogenesis Via Regulating Smads Signalling Pathway.

Comparative Analysis of the Placental Microbiome in Pregnancies with Late Fetal Growth Restriction versus Physiological Pregnancies

The Placental NLRP3 Inflammasome and Its Downstream Targets, Caspase-1 and Interleukin-6, Are Increased in Human Fetal Growth Restriction: Implications for Aberrant Inflammation-Induced Trophoblast Dysfunction

The fecal microbiota of gravidas with fetal growth restriction newborns characterized by metagenomic sequencing

The chimera‐type galectin‐3 is a positive modulator of trophoblast functions with dysregulated expression in gestational diabetes mellitus

Potential Association of Gut Microbial Metabolism and Circulating mRNA Based on Multiomics Sequencing Analysis in Fetal Growth Restriction

Relationships of levels of homocysteine, placental growth factor, folic acid and vitamin B12 in maternal blood and umbilical cord blood and their correlations with fetal growth restriction